These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17021762)

  • 1. Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.
    Doherty SD; Ni X; Doherty CB; Jones D; Zhao X; Owen LB; Duvic M
    Arch Dermatol Res; 2006 Dec; 298(7):353-6. PubMed ID: 17021762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
    Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
    Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
    Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F; Jansen PM; Vermeer MH; Willemze R
    Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
    Matejka M; Konrad K
    Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.
    Agar N; Whittaker SJ
    Br J Dermatol; 2008 Nov; 159(5):1197-9. PubMed ID: 18764843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of 100 Japanese patients with mycosis fungoides and Sézary syndrome.
    Suzuki SY; Ito K; Ito M; Kawai K
    J Dermatol Sci; 2010 Jan; 57(1):37-43. PubMed ID: 19931424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
    Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
    Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
    Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
    J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
    Gahongayire F
    Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M; Ono T
    Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of T-plastin in Sezary cells.
    Su MW; Dorocicz I; Dragowska WH; Ho V; Li G; Voss N; Gascoyne R; Zhou Y
    Cancer Res; 2003 Nov; 63(21):7122-7. PubMed ID: 14612505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
    Döbbeling U
    G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.